- Home
- SAVA vs SFBC Comparison
SAVA vs SFBC Comparison
Compare SAVA & SFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- SFBC
- Stock Information
- Founded
- SAVA 1998
- SFBC 1953
- Country
- SAVA United States
- SFBC United States
- Employees
- SAVA N/A
- SFBC N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- SFBC Savings Institutions
- Sector
- SAVA Health Care
- SFBC Finance
- Exchange
- SAVA Nasdaq
- SFBC Nasdaq
- Market Cap
- SAVA 137.2M
- SFBC 127.6M
- IPO Year
- SAVA N/A
- SFBC N/A
- Fundamental
- Price
- SAVA $1.38
- SFBC $50.65
- Analyst Decision
- SAVA Buy
- SFBC
- Analyst Count
- SAVA 3
- SFBC 0
- Target Price
- SAVA $54.50
- SFBC N/A
- AVG Volume (30 Days)
- SAVA 2.2M
- SFBC 2.0K
- Earning Date
- SAVA 05-09-2025
- SFBC 04-28-2025
- Dividend Yield
- SAVA N/A
- SFBC 1.51%
- EPS Growth
- SAVA N/A
- SFBC N/A
- EPS
- SAVA N/A
- SFBC 1.80
- Revenue
- SAVA N/A
- SFBC $35,777,000.00
- Revenue This Year
- SAVA N/A
- SFBC N/A
- Revenue Next Year
- SAVA N/A
- SFBC N/A
- P/E Ratio
- SAVA N/A
- SFBC $27.86
- Revenue Growth
- SAVA N/A
- SFBC N/A
- 52 Week Low
- SAVA $1.35
- SFBC $39.15
- 52 Week High
- SAVA $42.20
- SFBC $55.99
- Technical
- Relative Strength Index (RSI)
- SAVA 23.37
- SFBC 48.39
- Support Level
- SAVA $1.63
- SFBC $50.15
- Resistance Level
- SAVA $1.79
- SFBC $51.89
- Average True Range (ATR)
- SAVA 0.19
- SFBC 0.59
- MACD
- SAVA -0.14
- SFBC 0.03
- Stochastic Oscillator
- SAVA 1.76
- SFBC 44.86
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
About SFBC Sound Financial Bancorp Inc.
Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.